Zhongchao is a China-based platform company providing healthcare education, training, and patient management services, primarily focused on oncology and rare diseases. The company operates through two core platforms. MDMOOC is an online platform serving doctors, nurses, and other healthcare professionals with video courses, clinical case libraries, continuing education materials, and onsite training programs. Zhongxin Health is a WeChat-based patient management tool that helps oncology and rare disease patients track medication, manage dosing, and navigate treatment. Zhongchao's business model is B2B: pharmaceutical companies and not-for-profit organizations pay Zhongchao to build and manage dedicated drug education and patient management programs on its platforms, while doctors and patients access the platforms for free. Revenue is project-based, driven by the number of active programs and the scope of services per engagement. NFP customers account for roughly two-thirds of revenues, with pharmaceutical companies contributing most of the remainder, across a concentrated base of about 60 service clients. A notable activity is Zhongchao's "patient-aid project" model, under which pharma and NFP sponsors fund drug treatment columns on MDMOOC — covering around 160,000 patients across cancer and rare disease drug programs as of late 2025. Zhongchao previously operated a drug retail and distribution business, Xinjiang Pharmaceutical, which was wound down and shut in mid-2025. The company operates exclusively in China, with headquarters in Shanghai.